Sign Up to like & get
recommendations!
0
Published in 2017 at "Clinical Transplantation"
DOI: 10.1111/ctr.13084
Abstract: Chronic lung allograft dysfunction (CLAD) is the major barrier to better longterm survival in lung transplant recipients, and treatment options remain limited.1 The efficacy of azithromycin for the treatment and prevention of CLAD has been…
read more here.
Keywords:
recurrent acr;
ecp;
clad;
treatment ... See more keywords